Experimental evidence for the age dependence of tau protein spread in the brain
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
We observed enhanced tau spreading in the aging mouse brain and tau misfolding in brain regions vulnerable in Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Enhanced neuron-to-neuron propagation of mutant P301Ltau in vivo. (A) Schematic showing the AAV sequence, the mRNA, and the proteins encoded in AAV CBA.eGFP.2a.huTau (WTtau and P301Ltau), as well as the tau protein propagation principle and detection methodology. Using a self-cleaving 2a peptide, transduced “donor” neurons express both eGFP and human tau as individual proteins. The propagation of tau can be visualized by immunofluorescence labeling of postmortem brain sections or fixed neurons in culture: Human tau detected in “recipient” neurons that do not express the fluorescence transduction marker eGFP indicates the propagation of tau between cells. Thereby, the upstream location of the GFP transduction marker prevents the detection of false positives that could occur due to incomplete translation of the mRNA. (B) Schematic for the unilateral injection of AAV eGFP-2a-huTau into the EC (green) and the experimental work flow. The location of the EC, the HPC (and subregion CA1), and the dentate gyrus (DG) in horizontal mouse brain sections is indicated. (C) Example of the immunofluorescence labeling of human tau (red) and GFP (green) in a horizontal brain section of a GFP-2a-WTtau–injected mouse with many huTau recipient cells: [huTau+/GFP−] cells, which received tau by cell-to-cell propagation (white arrowheads in close-ups 1 and 2), can be seen adjacent to the EC injection side (1) and in synaptic connected area CA1 (2). Cells transduced with the AAV (GFP+) can, in this specific case, be found in the EC and CA3. (D) Quantification of tau propagation (no. of recipient cells/no. of transduced cells) was done by counting all recipient (huTau+, red) and donor neurons (GFP+, green) in the entire ipsilateral EC and HPC formation (dashed white line). A higher propagation (P = 0.0472) was detected for P301Ltau compared to WTtau. (E) Scatterplot shows the average of recipient versus donor cells per mouse. Mean ± SEM, n = 3 animals per group and n = 4 to 5 brain sections per animal; single data points represent the mean per animal; unpaired two-tailed Student’s t test with Welch’s correction.](https://figures.cochat.ai/paper-figures/0d31dc33f7054e8d8166fe997bc5836c/experimental-evidence-for-the-age-dependence-of-tau-protein-spread-in-the-brain-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A newly developed model of tau spread has been described recently that utilizes an adeno-associated virus (AAV) and allows reliable discrimination of neurons that have been transduced to express human tau (hTau) versus neurons that receive hTau protein through spread19.”
From LRP1 is a master regulator of tau uptake and spread (2020) · cites this paper as [19]
In the citing paper
“Progressive supranuclear palsy (PSP) is another form of tauopathy commonly observed in individuals around their mid-60 years. Its prevalence notably increases with advancing age, often manifesting more prominently in those aged 70 years and older. This condition is characterized by the progressive accumulation of the tau protein in the brain, which becomes more prevalent with advancing age.26”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Self-citationStaging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
Self-citationArnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Self-citationSzymczak, A. L., Workman, C. J., Wang, Y., Vignali, K. M., Dilioglou, S., Vanin, E. F., & Vignali, D. A. A. (2004) · Nature Biotechnology · doi:10.1038/nbt957 · Cited by 1,059
Trans-Synaptic Spread of Tau Pathology In Vivo
Liu, L., Drouet, V., Wu, J. W., Witter, M. P., Small, S. A., Clelland, C., & Duff, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031302 · Cited by 1,002
Neuronal activity enhances tau propagation and tau pathology in vivo
Wu, J. W., Hussaini, S. A., Bastille, I. M., Rodriguez, G. A., Mrejeru, A., Rilett, K., Sanders, D. W., Cook, C., Fu, H., Boonen, R. A. C. M., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4328 · Cited by 820
Cited by
LRP1 is a master regulator of tau uptake and spread
Rauch, J. N., Luna, G., Guzman, E., Audouard, M., Challis, C., Sibih, Y. E., Leshuk, C., Hernandez, I., Wegmann, S., Hyman, B. T., et al. (2020) · Nature · doi:10.1038/s41586-020-2156-5 · Cited by 541
Self-citationSynaptic degeneration in Alzheimer disease
Tzioras, M., McGeachan, R. I., Durrant, C. S., & Spires-Jones, T. L. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00749-z · Cited by 504
Xie, C., Zhuang, X.-X., Niu, Z., Ai, R., Lautrup, S., Zheng, S., Jiang, Y., Han, R., Gupta, T. S., Cao, S., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00819-5 · Cited by 336
Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice
Caballero, B., Bourdenx, M., Luengo, E., Diaz, A., Sohn, P. D., Chen, X., Wang, C., Juste, Y. R., Wegmann, S., Patel, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22501-9 · Cited by 223
Self-citationColom-Cadena, M., Davies, C., Sirisi, S., Lee, J.-E., Simzer, E. M., Tzioras, M., Querol-Vilaseca, M., Sánchez-Aced, É., Chang, Y. Y., Holt, K., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.020 · Cited by 224
Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases
Salehi, B., Calina, D., Docea, A., Koirala, N., Aryal, S., Lombardo, D., Pasqua, L., Taheri, Y., Marina Salgado Castillo, C., Martorell, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020430 · Cited by 196
Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease
d‘Errico, P., & Meyer-Luehmann, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00265 · Cited by 175
Lau, V., Ramer, L., & Tremblay, M.-È. (2023) · Nature Communications · doi:10.1038/s41467-023-37304-3 · Cited by 167
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Neurodegenerative Disease Tauopathies
Creekmore, B. C., Watanabe, R., & Lee, E. B. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-120750 · Cited by 165
Microglia in Alzheimer’s Disease in the Context of Tau Pathology
Perea, J. R., Bolós, M., & Avila, J. (2020) · Biomolecules · doi:10.3390/biom10101439 · Cited by 123
Cooper, J. M., Lathuiliere, A., Migliorini, M., Arai, A. L., Wani, M. M., Dujardin, S., Muratoglu, S. C., Hyman, B. T., & Strickland, D. K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100715 · Cited by 122
“(21) employed a unique adeno-associated virus construct (expressing GFP-2AhTau) that is capable of discriminating between transduced cells and cells internalizing secreted tau (11) to demonstrate that neuronal LRP1 expressed in the brain of mice readily internalizes neuronally secreted tau.”
MethodSelf-citationKobro-Flatmoen, A., Lagartos-Donate, M. J., Aman, Y., Edison, P., Witter, M. P., & Fang, E. F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101307 · Cited by 119
Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
Silva, M. C., & Haggarty, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238948 · Cited by 85
Sun, Q., Zhang, J., Li, A., Yao, M., Liu, G., Chen, S., Luo, Y., Wang, Z., Gong, H., Li, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28493-4 · Cited by 93
Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation
Saroja, S. R., Gorbachev, K., Julia, T., Goate, A. M., & Pereira, A. C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2108870119 · Cited by 75
Bassoon contributes to tau-seed propagation and neurotoxicity
Martinez, P., Patel, H., You, Y., Jury, N., Perkins, A., Lee-Gosselin, A., Taylor, X., You, Y., Viana Di Prisco, G., Huang, X., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01191-6 · Cited by 68
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy
Ye, J., Wan, H., Chen, S., & Liu, G. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385847 · Cited by 80
Alexander, C., Parsaee, A., & Vasefi, M. (2023) · Biology · doi:10.3390/biology12111453 · Cited by 62
Pedrioli, G., & Paganetti, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.595515 · Cited by 55
Astrocytes in selective vulnerability to neurodegenerative disease
Zimmer, T. S., Orr, A. L., & Orr, A. G. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.02.008 · Cited by 48
Raha, A. A., Biswas, A., Henderson, J. W., Chakraborty, S., Holland, A. J., Friedland, R. P., Mukaetova‐Ladinska, E. B., Zaman, S. H., & Raha‐Chowdhury, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031060 · Cited by 55
McAllister, B. B., Lacoursiere, S. G., Sutherland, R. J., & Mohajerani, M. H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.026 · Cited by 54
Tau internalization: A complex step in tau propagation
Zhao, J., Wu, H., & Tang, X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101272 · Cited by 49
Kok, F. K., van Leerdam, S., & de Lange, E. C. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-210607 · Cited by 46
Goodwin, M. S., Sinyavskaya, O., Burg, F., O’Neal, V., Ceballos-Diaz, C., Cruz, P. E., Lewis, J., Giasson, B. I., Davies, P., Golde, T. E., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.007 · Cited by 44
Yao, D., Li, T., Yu, L., Hu, M., He, Y., Zhang, R., Wu, J., Li, S., Kuang, W., Yang, X., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1351792 · Cited by 51
Self-citationAmaral, A. C., Perez-Nievas, B. G., Siao Tick Chong, M., Gonzalez-Martinez, A., Argente-Escrig, H., Rubio-Guerra, S., Commins, C., Muftu, S., Eftekharzadeh, B., Hudry, E., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102058 · Cited by 42
Self-citationAbnormal Homocysteine Metabolism: An Insight of Alzheimer’s Disease from DNA Methylation
Pi, T., Liu, B., & Jing-shan, S. (2020) · Behavioural Neurology · doi:10.1155/2020/8438602 · Cited by 46
Annadurai, N., Sanctis, J. B. D., Hajdúch, M., & Das, V. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113756 · Cited by 42
Cai, Y. Q., Du, J., Li, A., Zhu, Y., Xu, L., Sun, K., Ma, S., Guo, T., & Initiative, A. D. N. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01178-w · Cited by 48
Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake
De La‐Rocque, S., Moretto, E., Butnaru, I., & Schiavo, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15144 · Cited by 39
Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs
Moos, W. H., Faller, D. V., Glavas, I. P., Harpp, D. N., Kanara, I., Mavrakis, A. N., Pernokas, J., Pernokas, M., Pinkert, C. A., Powers, W. R., et al. (2020) · BioResearch open access · doi:10.1089/biores.2020.0004 · Cited by 39
Jacquet, A. D. R., Denis, H. L., Cicchetti, F., & Alpaugh, M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00999-7 · Cited by 38
Lactylation of tau in human Alzheimer's disease brains
Zhang, X., Liu, Y., Rekowski, M. J., & Wang, N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14481 · Cited by 50
Tau Seeding Mouse Models with Patient Brain-Derived Aggregates
Robert, A., Schöll, M., & Vogels, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116132 · Cited by 38
Carroll, T., Guha, S. K., Nehrke, K. W., & Johnson, G. V. W. (2021) · Biology · doi:10.3390/biology10101047 · Cited by 42
Nuclear face of Tau: an inside player in neurodegeneration
Younas, N., Saleem, T., Younas, A., & Zerr, I. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01702-x · Cited by 35
Ni, J., Xie, Z., Quan, Z., Meng, J., & Qing, H. (2023) · Glia · doi:10.1002/glia.24465 · Cited by 34
The autophagy adaptor TRIAD3A promotes tau fibrillation by nested phase separation
Zhou, J., Chuang, Y. ‘., Redding‐Ochoa, J., Zhang, R., Platero, A. J., Barrett, A., Troncoso, J. C., Worley, P. F., & Zhang, W. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01461-4 · Cited by 36
Evidence for trans-synaptic propagation of oligomeric tau in human progressive supranuclear palsy
McGeachan, R. I., Keavey, L., Simzer, E. M., Chang, Y. Y., Rose, J. L., Spires-Jones, M. P., Gilmore, M., Holt, K., Meftah, S., Ravingerova, N., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01992-5 · Cited by 44
Jash, S., Banerjee, S., Cheng, S., Wang, B., Qiu, C., Kondo, A., Ernerudh, J., Zhou, X. Z., Lu, K. P., & Sharma, S. (2023) · Nature Communications · doi:10.1038/s41467-023-41144-6 · Cited by 27
Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?
Brackhan, M., Arribas-Blázquez, M., & Lastres‐Becker, I. (2023) · Antioxidants · doi:10.3390/antiox12081564 · Cited by 33
Implication of tau propagation on neurodegeneration in Alzheimer’s disease
Lamontagne-Kam, D., Ulfat, A. K., Hervé, V., Vu, T.-M., & Brouillette, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1219299 · Cited by 31
SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy
Ni, R., Zarb, Y., Kuhn, G. A., Müller, R., Yundung, Y., Nitsch, R. M., Kulic, L., Keller, A., & Klohs, J. (2020) · Magnetic Resonance Materials in Physics, Biology and Medicine · doi:10.1007/s10334-020-00855-3 · Cited by 24
Ma, Y., Wu, J., Xu, W., Shen, X., Wang, H.-F., Hou, X., Cao, X., Bi, Y., Dong, Q., Feng, L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200410 · Cited by 25
Olesen, M. A., Pradenas, E., Villavicencio-Tejo, F., Porter, G. A., Johnson, G. V. W., & Quintanilla, R. A. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.03.017 · Cited by 26
Morón-Oset, J., Supèr, T., Eßer, J., Isaacs, A. M., Grönke, S., & Partridge, L. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0860-x · Cited by 21
Jiao, F., Wang, M., Sun, X., Ju, Z., Lu, J., Wang, L., Jiang, J., & Zuo, C. (2023) · Brain Sciences · doi:10.3390/brainsci13020367 · Cited by 18
Lymphocyte‐Activation Gene 3 Facilitates Pathological Tau Neuron‐to‐Neuron Transmission
Chen, C., Kumbhar, R., Wang, H., Yang, X., Gadhave, K., Rastegar, C. T., Kimura, Y., Behensky, A. A., Kotha, S., Kuo, G., et al. (2024) · Advanced Science · doi:10.1002/advs.202303775 · Cited by 25
Colom‐Cadena, M., Davies, C., Sirisi, S., Lee, J.-E., Simzer, E. M., Tzioras, M., Querol‐Vilaseca, M., Sánchez‐Aced, É., Chang, Y. Y., Holt, K., et al. (2023) · medRxiv · doi:10.1101/2023.03.15.23287268 · Cited by 19
Wang, Z.-T., Li, K., Tan, C., Xu, W., Shen, X., Cao, X., Wang, P., Bi, Y., Dong, Q., Tan, L., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210140 · Cited by 23
Gan, Q., Ding, Y., Peng, M., Chen, L., Dong, J., Hu, J., & Ma, Y. (2023) · Biomolecules · doi:10.3390/biom13050873 · Cited by 17
Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects
Collins, H. M., & Greenfield, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116222 · Cited by 21
Alpaugh, M., Denis, H. L., & Cicchetti, F. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01350-4 · Cited by 17
Positron Emission Tomography in Animal Models of Tauopathies
Cao, L., Kong, Y., Ji, B., Ren, Y., Guan, Y., & Ni, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.761913 · Cited by 16
Arc mediates intercellular tau transmission via extracellular vesicles
Tyagi, M., de Hoog, E., Grega, M., Sullivan, K. R., Walker, A., Chadha, R., Northrop, A., Fábián, B., Hummer, G., Fuxreiter, M., et al. (2026) · Cell · doi:10.1016/j.cell.2026.06.008 · Cited by 26
Self-citationAlternatives to amyloid for Alzheimer's disease therapies—a symposium report
Cable, J., Holtzman, D. M., Hyman, B. T., Tansey, M. G., Colonna, M., Kellis, M., Brinton, R. D., Albert, M., Wellington, C. L., Sisodia, S. S., et al. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14371 · Cited by 13
Self-citationStrategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease
Heuer, S. E., Bloss, E. B., & Howell, G. R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109987 · Cited by 16
Roqanian, S., Ahmadian, S., Nabavi, S. M., Pakdaman, H., Shafiezadeh, M., Goudarzi, G., & Shahpasand, K. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25024 · Cited by 15
Sowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer’s Disease
Bell, B. J., Malvankar, M. M., Tallon, C., & Slusher, B. S. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00531 · Cited by 16
ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease
Lennol, M. P., Bordier, C., Kamelher, L., Ulrich, J. D., Holtzman, D. M., & Gratuze, M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250965 · Cited by 15
Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice
Huang, M., Tallon, C., Zhu, X., Huizar, K. D. J., Picciolini, S., Thomas, A. G., Tenora, L., Liyanage, W., Rodà, F., Gualerzi, A., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092364 · Cited by 11
Kourti, M., & Metaxas, A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106427 · Cited by 18
Shoaib, M. M., Hayat, M. S., Nadeem, Z. A., Shoaib, M. M., Sohail, S., Mirza, A. T., & Shahid, F. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70004 · Cited by 13
Kara, E., Crimi, A., Wiedmer, A. E., Emmenegger, M., Manzoni, C., Bandrés‐Ciga, S., D’Sa, K., Reynolds, R. H., Botía, J. A., Losa, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109189 · Cited by 13
Self-citationAge-dependent increase of cytoskeletal components in sensory axons in human skin
Metzner, K., Darawsha, O., Wang, M., Gaur, N., Cheng, Y., Rödiger, A., Frahm, C., Witte, O. W., Perocchi, F., Axer, H., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.965382 · Cited by 12
MCP-1 levels in astrocyte-derived exosomes are changed in preclinical stage of Alzheimer's disease
Wang, T., Yao, Y., Han, C., Li, T., Du, W., Xue, J., Han, Y., & Cai, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1119298 · Cited by 15
The role of wild-type tau in Alzheimer’s disease and related tauopathies
Lo, C. H., & Sachs, J. N. (2020) · JoLS Journal of Life Sciences · doi:10.36069/jols/20201201 · Cited by 24
Zhou, Z., Fang, C., Shen, Y., Zhang, X., Li, H., & Zhang, Y. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.135971 · Cited by 12
Anton, P. E., Maphis, N. M., Linsenbardt, D. N., & Coleman, L. G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-81908-7_10 · Cited by 13
Tauopathy after long‐term cervical lymphadenectomy
Wu, C., Yuan, J., Tian, Y., Wang, Y., He, X., Zhao, K., Huang, J., & Jiang, R. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70136 · Cited by 16
Santambrogio, A., Horne, R. I., Metrick, M. A., Gallagher, N. C. T., Brotzakis, Z. F., Rinauro, D. J., Vourkou, E., Papanikolopoulou, K., Skoulakis, E. M. C., Linse, S. S., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c12812 · Cited by 16
Loon, A. R., Zamudio, F., Sanneh, A., Brown, B., Smeltzer, S., Brownlow, M. L., Quadri, Z., Peters, M. M., Weeber, E. J., Nash, K. R., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00408-z · Cited by 13
Abed, S. S., Hamdan, F. B., Hussein, M. M., & Al-Mayah, Q. S. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2022-0251 · Cited by 13
Apolipoprotein E isoform does not influence trans-synaptic spread of tau pathology in a mouse model
Davies, C., Tulloch, J., Yip, E., Currie, L., Colom‐Cadena, M., Wegmann, S., Hyman, B. T., Wilkins, L., Hooley, M., Tzioras, M., et al. (2023) · Brain and Neuroscience Advances · doi:10.1177/23982128231191046 · Cited by 11
Self-citationSpreading of Tau Protein Does Not Depend on Aggregation Propensity
Rodrigues, S., Anglada‐Huguet, M., Hochgräfe, K., Kaniyappan, S., Wegmann, S., & Mandelkow, E. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02143-w · Cited by 13
Self-citationContextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease
Lalwani, R. C., Volmar, C., Wahlestedt, C., Webster, K. A., & Shehadeh, L. A. (2023) · Biomedicines · doi:10.3390/biomedicines11123232 · Cited by 15
Lu, K. P., & Zhou, X. Z. (2024) · Science Signaling · doi:10.1126/scisignal.adi8743 · Cited by 12
Magnetic Resonance Imaging in Tauopathy Animal Models
Ni, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.791679 · Cited by 11
Tau propagation is dependent on the genetic background of mouse strains
Dujardin, S., Fernandes, A., Bannon, R., Commins, C., De Los Santos, M., Kamath, T. V., Hayashi, M., & Hyman, B. T. (2022) · Brain Communications · doi:10.1093/braincomms/fcac048 · Cited by 11
“We have previously used this system to demonstrate that age impacts the likelihood of propagation of tau to downstream neurons.(5) We now have examined a set of genetically diverse mouse strains, to begin to explore the possibility that heritable factors might impact tau propagation.”
MethodSelf-citationHu, N., Hu, Z., Ondrejčák, T., Yu, P., Zhang, Y., Yang, Y., Klyubin, I. V., Kennelly, S., & Rowan, M. J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.360166 · Cited by 11
Ramasubramanian, B., Reddy, V. S., Chellappan, V., & Ramakrishna, S. (2022) · Biosensors · doi:10.3390/bios12121176 · Cited by 13
Vogels, T., Vargová, G., Brezováková, V., Quint, W. H., & Hromádka, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200047 · Cited by 11
Phosphorylation of Truncated Tau Promotes Abnormal Native Tau Pathology and Neurodegeneration
Li, L., Jiang, Y., Wu, G., Mahaman, Y. A. R., Ke, D., Wang, Q., Zhang, B., Wang, J., Li, H., Liu, R., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-022-02972-7 · Cited by 13
Glucocorticoid stress hormones stimulate vesicle-free Tau secretion and spreading in the brain
Yu, Q., Du, F., Belli, I., Gomes, P., Sotiropoulos, I., & Waites, C. L. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06458-3 · Cited by 14
Serum Oligomeric α-Synuclein and p-tau181 in Progressive Supranuclear Palsy and Parkinson’s Disease
Cristiani, C. M., Scaramuzzino, L., Quattrone, A., Parrotta, E. I., Cuda, G., & Quattrone, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136882 · Cited by 10
Li, Y., Dai, J., Kametani, F., Yazaki, M., Ishigami, A., Mori, M., Miyahara, H., & Higuchi, K. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.03.002 · Cited by 11
Rasmussen, J., Ewing, A. D., Bodea, L., Bodea, G. O., Gearing, M., & Faulkner, G. J. (2021) · Brain Pathology · doi:10.1111/bpa.13018 · Cited by 12
Murakami, R., Watanabe, H., Hashimoto, H., Kashiwagi-Hakozaki, M., Hashimoto, T., Karch, C. M., the Dominantly Inherited Alzheimer Network (DIAN), Iwatsubo, T., & Okano, H. (2024) · The Journal of Neuroscience · doi:10.1523/jneurosci.1709-23.2024 · Cited by 9
Frost, B. E., Rowe, J. B., Akinyemi, R., Abisambra, J. F., Ashton, N. J., Brendel, M., Buée, L., Butler, D., Carrillo, M. C., Chung, P. S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70078 · Cited by 12
Self-citationIgLON5 autoimmune antibodies activate Tau via neuronal hyperactivity
Askin, B., Kilic, C., Gómez, C. C., Duong, S. L.-L., Dominguez‐Baquero, A., Goihl, A., Nalbach, K., Petushi, J., Grundschöttel, P., Wagner, J., et al. (2026) · Science Advances · doi:10.1126/sciadv.aec2042 · Cited by 9
Self-citationSymmetric and Asymmetric Synapses Driving Neurodegenerative Disorders
Romaus‐Sanjurjo, D., Custodia, A., Aramburu-Núñez, M., Posado-Fernández, A., Vázquez‐Vázquez, L., Camino-Castiñeiras, J., Leira, Y., Peleteiro, J. M. P., Aldrey, J. M., Ouro, A., et al. (2021) · Symmetry · doi:10.3390/sym13122333 · Cited by 9
Tau modulates visual plasticity in adult and old mice
Rodriguez, L., Joly, S., Zine-Eddine, F., Mdzomba, J. B., & Pernet, V. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.024 · Cited by 10
Noguchi, D., Watamura, N., Nikkuni, M., Saido, T. C., Goshima, Y., & Ohshima, T. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04721-y · Cited by 9
Tauopathies: Emerging discoveries on tau protein, with a special focus on Alzheimer's disease
Hattiholi, A., Hegde, H., & Shetty, S. K. (2025) · Neuropeptides · doi:10.1016/j.npep.2025.102536 · Cited by 11
Zhang, Y., Yang, Y., Hu, Z., Zhu, M., Qin, S., Yu, P., Li, B., Xu, J., Ondrejčák, T., Klyubin, I. V., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220351 · Cited by 8
Characterizing the spatiotemporal variability of Alzheimer's disease pathologyPreprint
Vogel, J. W., Young, A., Oxtoby, N., Smith, R., Ossenkoppele, R., Strandberg, O., Joie, R. L., Aksman, L., Grothe, M., Iturria-Medina, Y., et al. (2020) · medRxiv · doi:10.1101/2020.08.20.20176883 · Cited by 10
Exploring the origins of frequent tau-PET signal in vermal and adjacent regions
Kling, A., Kusche‐Palenga, J., Palleis, C., Jäck, A., Bernhardt, A. M., Frontzkowski, L. K., Roemer, S. N., Slemann, L., Zaganjori, M., Scheifele, M., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07199-x · Cited by 8
RNA Granules at the Crossroads of Synaptic Dysfunction and Neurodegeneration
Nóbrega‐Martins, R., Barros‐Santos, B., Papadimitriou, G., Sotiropoulos, I., Wolozin, B. L., & Silva, J. M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70269 · Cited by 12
Metadata
- Authors
- Wegmann, S., Bennett, R. E., Delorme, L., Robbins, A. B., Hu, M., MacKenzie, D., Kirk, M. J., Schiantarelli, J., Tunio, N., Amaral, A. C., Fan, Z., Nicholls, S., Hudry, E., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Corresponding author
- Wegmann, Susanne
- Hyman, Bradley T.
- ORCID
- Venue
- Science Advances
- Published
- 2019-06
- Volume
- 5
- Issue
- 6
- Pages
- eaaw6404-eaaw6404
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6594764
- OpenAlex
- W2953812575
- Cited by
- 144
- References
- 39
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 21 · 2023: 27 · 2022: 20 · 2021: 23 · 2020: 23 · 2019: 2
- FWCI
- 11.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DZNE Pub (publishedVersion, other-oa)
- Funders
- National Institute on Aging
- Ruth K. Broad Biomedical Research Foundation
- Massachusetts General Hospital
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Bright Focus Foundation
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, Alzheimer's disease, tau misfolding, tau spread, age-related risk, entorhinal cortex, hippocampus, striatum, regional vulnerability, tau tangles, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cell Line, Disease Models, Animal, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Neurons, tau Proteins, Disease Progression, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.